Related Experiment Video
Updated: Apr 19, 2026

13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
8.4K
Screening methods for AMP-activated protein kinase modulators: a patent review
Joungmok Kim1, Joonsoo Shin, Joohun Ha
1Kyung Hee University, School of Dentistry, Oral Biochemistry and Molecular Biology , Seoul , Republic of Korea.
Expert Opinion on Therapeutic Patents
|December 24, 2014
Summary
AMP-activated protein kinase (AMPK) is crucial for cellular energy balance and disease treatment. Structure-based assays show promise for discovering potent and specific AMPK modulators, advancing drug development for various conditions.
Area of Science:
- Biochemistry and Molecular Biology
- Drug Discovery and Development
- Cellular Metabolism
Background:
- AMP-activated protein kinase (AMPK) acts as a cellular energy sensor, regulating homeostasis.
- AMPK plays significant roles in tumorigenesis, lifespan, and autophagy.
- AMPK is a key therapeutic target for metabolic disorders and cancer.
Purpose of the Study:
- To analyze and discuss screening methods for identifying compounds that modulate AMPK activity.
- To highlight the importance of understanding modulator mechanisms for drug design.
- To evaluate the potential of structure-based assays for discovering novel AMPK modulators.
Main Methods:
- Comprehensive analysis of screening methods described in patent and scientific literature.
- Discussion of direct AMPK modulator features, physiological relevance, and structural context.
- Evaluation of classical enzyme assays versus structure-based assay systems.
Main Results:
- Classical enzyme assays and cell-based physiological assays lack mechanistic insights.
- Patented assays utilizing specific AMPK domains or its 3D structure are emerging.
- Identification of A-769662 and C-2/C-13 demonstrates the efficacy of structure-based approaches.
Conclusions:
- Understanding modulator mechanisms is vital for developing drugs with improved efficacy, specificity, and stability.
- Structure-based assays offer a promising avenue for discovering potent and specific AMPK modulators.
- Advancements in screening systems are crucial for targeting AMPK in various human diseases.

